ロード中...
Statistical and regulatory considerations in assessments of interchangeability of biological drug products
When the patent of a brand-name, marketed drug expires, new, generic products are usually offered. Small-molecule generic and originator drug products are expected to be chemically identical. Their pharmaceutical similarity can be typically assessed by simple regulatory criteria such as the expectat...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4046084/ https://ncbi.nlm.nih.gov/pubmed/24832831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10198-014-0589-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|